About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in California | 705 Studies

Clinical Trials Ovarian CancerCalifornia

Ovarian Cancer Clinical Trials in California

Find 705 clinical trials for ovarian cancer near California. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 481-500 of 705 trials

Enrolling by invitationQuest to Analyze One Thousand Humans MeditatingThis study will be focused on assessing the molecular, physiological, and emotional correlates of an intensive meditation experience in the context of a retreat setting in a large…NCT06583395·Palm Desert, California Unknown3D Prediction of Patient-Specific ResponseThis is a prospective, non-randomized, observational registry study evaluating a patient-specific ex vivo 3D (EV3D) assay for drug response using a patient's own biopsy or…NCT03561207·Little Rock, Arkansas and 8 others CompletedPatient Reported Symptoms in Ovarian Cancer (PRECISION)This multicenter, observational, prospective study will include approximately 20 US-based centers, and approximately 142 patients diagnosed with epithelial ovarian cancer, primary…NCT01422265·Goodyear, Arizona and 30 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedCarboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma CancerThis phase I trial is studying the side effects of giving carboplatin and paclitaxel together with pegfilgrastim in treating patients with stage III or stage IV ovarian…NCT00352300·Orange, California and 10 others

Active not recruitingPaclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerThis phase III clinical trial studies two different dose schedules of paclitaxel to see how well they work in combination with carboplatin with or without bevacizumab in treating…NCT01167712·Birmingham, Alabama and 563 others

CompletedA Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid TumorsThe primary purpose of this Phase 1, open-label study is to evaluate the safety, pharmacokinetics, and preliminary efficacy of ABBV-368 as a monotherapy and in combination with…NCT03071757·La Jolla, California and 26 others

Active not recruitingGemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube CancerThis randomized phase II trial studies how well ATR kinase inhibitor M6620 (M6620) and gemcitabine hydrochloride work compared to standard treatment with gemcitabine hydrochloride…NCT02595892·Phoenix, Arizona and 16 others

Active not recruitingComparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic AgentsThis phase II trial studies the possible benefits of treatment with different combinations of the drugs durvalumab, olaparib and cediranib vs. the usual treatment in patients with…NCT04739800·Anchorage, Alaska and 390 others

TerminatedDose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid TumorsThis is a Phase 1, multicenter, open-label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and preliminary evidence of antitumor…NCT04931823·Los Angeles, California and 7 others

RecruitingA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsThe purpose of this study is to find out whether the study drug, LY4052031, is safe, tolerable and effective in participants with advanced, or metastatic solid tumors including…NCT06465069·Duarte, California and 38 others

Active not recruitingCarboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube CancerThis randomized phase III trial studies carboplatin, paclitaxel and gemcitabine hydrochloride when given together with or without bevacizumab after surgery to see how well it…NCT00565851·Anchorage, Alaska and 708 others

Active not recruitingFc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced CancerThis study is an open-label, Phase 1, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) profiles of a novel fragment…NCT03860272·Scottsdale, Arizona and 17 others

AvailableExpanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesThe objective of this expanded access program is to provide ulixertinib (BVD-523) for compassionate use in advanced cancer patients with MAPK pathway-altered solid tumor(s)…NCT04566393·Mobile, Alabama and 25 others

CompletedOlaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum TreatmentsComparison of olaparib vs. physician's choice of single agent standard of care non-platinum based chemotherapy in patients with germline Breast Cancer susceptibility gene (gBRCA)…NCT02282020·Birmingham, Alabama and 93 others

RecruitingStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab AdizutecanCancer is a condition where cells in a specific part of body grow and reproduce uncontrollably.NCT05005403·Duarte, California and 47 others

CompletedSafety Study of ²¹²Pb-TCMC-Trastuzumab Radio ImmunotherapyMonoclonal antibodies can transport and deliver radioactive elements capable of releasing sufficient amounts of energy to destroy tumor cells.NCT01384253·Birmingham, Alabama and 1 other

RecruitingStudy of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian CancerThe goal of this clinical study is to learn more about the safety, tolerability, and preliminary effectiveness of TUB-040 when given in combination with standard ovarian cancer…NCT07736937·Los Angeles, California and 7 others

RecruitingA Phase I/II Study of VLS-1488 in Subjects With Advanced CancerThis is a first-in-human phase I/II study to examine the safety, tolerability and preliminary efficacy of VLS-1488 in subjects with advanced cancers.NCT05902988·Los Angeles, California and 13 others

CompletedTissue Expansion in Breast Reconstruction Without DrainsThe primary objective of this small feasibility pilot study is to demonstrate that implant-based breast reconstruction (after treatment for cancer) can successfully be performed…NCT03784859·Los Angeles, California

CompletedSurvivorship Care Planning in Improving Quality of Life in Survivors of Ovarian CancerThis pilot clinical trial studies survivorship care planning in supporting quality of life in ovarian cancer survivors following primary treatment.NCT02082470·Duarte, California

PreviousPage 25 of 36Next

Other Conditions in California

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia